Company Filing History:
2 out of 2 
1 out of 1,556 
1 out of 8,693 
Years Active: 2011-2018
Title: Stephen Whitney: Innovator in HIV Research
Introduction
Stephen Whitney is a notable inventor based in Silver Spring, MD (US), recognized for his contributions to HIV research. He holds 2 patents that focus on innovative methods and compositions related to HIV envelope proteins. His work aims to advance the development of vaccines against HIV, showcasing his commitment to addressing critical health challenges.
Latest Patents
Whitney's latest patents include "Truncated HIV envelope proteins (ENV), methods and compositions related thereto." This patent provides methods and related compositions for novel HIV envelope proteins, including isolated nucleic acid and protein sequences suitable for use as vaccines against HIV. Another significant patent is "Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods." This invention discloses nucleic acid compositions designed to induce an immune response against HIV, utilizing a DNA composition that encodes various HIV envelope glycoproteins.
Career Highlights
Throughout his career, Stephen Whitney has worked with reputable organizations, including Advanced Bioscience Laboratories, Inc. and the University of Massachusetts. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Whitney has collaborated with notable coworkers such as Vaniambadi Kalyanaraman and Shan Lu. These partnerships have further enriched his research and innovation in the field of HIV.
Conclusion
Stephen Whitney's work in HIV research exemplifies the impact of innovation in addressing global health issues. His patents and collaborations reflect a dedication to advancing medical science and improving public health outcomes.